Banner - NPPA Connect

|Articles|March 8, 2023

Spotlighting Women In Dermatology

Author(s)Emma Andrus, Assistant Editor

This International Women's Day, the Dermatology Times® team is taking the time to spotlight women in the dermatology field.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Content

1 expert is featured in this series

Why Patient-Reported Outcomes Matter in Psoriasis Care

ByTina Bhutani-Jacques, MD

September 11th 2026

1 expert is featured in this series

Addressing Steroid Fear with Non-Steroidal Treatment Options in Psoriasis

ByTina Bhutani-Jacques, MD

September 4th 2026

1 expert is featured in this series

Setting Realistic Treatment Goals for Localized Plaque Psoriasis

ByTina Bhutani-Jacques, MD

September 4th 2026

1 expert is featured in this series

Case 3: Redefining How We Classify Psoriasis Severity

ByTina Bhutani-Jacques, MD

August 28th 2026

1 expert is featured in this series

Why One Foam Works for Scalp and Body Psoriasis

ByTina Bhutani-Jacques, MD

August 28th 2026

Latest CME

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hadar Lev-Tov, MD; Martina Porter, MD

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Trending on Dermatology Times

FDA Grants Priority Review to Zasocitinib for Moderate-to-Severe Plaque Psoriasis

How Emerging Androgenetic Alopecia Therapies Target DHT at the Scalp Level

FDA Approves Ameluz Red Light PDT for Superficial Basal Cell Carcinoma

Tildrakizumab Partially Reverses Epigenetic Aging in Psoriasis, Pilot Study Shows

Merz Expands BELOTERO Portfolio With Two New FDA-Approved Hyaluronic Acid Fillers